EX-5.1 2 d604664dex51.htm EX-5.1 EX-5.1

Exhibit 5.1

 

       

12636 High Bluff Drive, Suite 400

San Diego, California 92130-2071

Tel: +1.858.523.5400 Fax: +1.858.523.5450

www.lw.com

LOGO

   
 

FIRM / AFFILIATE OFFICES

   

Abu Dhabi

 

Milan

   

Barcelona

 

Moscow

   

Beijing

 

Munich

   

Boston

 

New Jersey

   

Brussels

 

New York

   

Chicago

 

Orange County

October 1, 2013

   

Doha

 

Paris

   

Dubai

 

Riyadh

   

Düsseldorf

 

Rome

   

Frankfurt

 

San Diego

   

Hamburg

 

San Francisco

   

Hong Kong

 

Shanghai

   

Houston

 

Silicon Valley

   

London

 

Singapore

   

Los Angeles

 

Tokyo

   

Madrid

 

Washington, D.C.

Evoke Pharma, Inc.

12555 High Bluff Drive, Suite 385

San Diego, CA 92130

 

 

Re:

Registration Statement on Form S-8; 1,323,250 Shares of Common Stock, par value $0.0001 per share

Ladies and Gentlemen:

We have acted as special counsel to Evoke Pharma, Inc., a Delaware corporation (the “Company”), in connection with the proposed issuance of an aggregate of 1,323,250 shares of common stock, $0.0001 par value per share (the “Shares”), of the Company, pursuant to the Company’s 2007 Equity Incentive Plan, as amended (the “2007 Plan”), the Company’s 2013 Equity Incentive Award Plan (the “2013 Plan”) and the Company’s 2013 Employee Stock Purchase Plan (the “ESPP,” and together with the 2007 Plan and the 2013 Plan, the “Plans”). The Shares are included in a registration statement on Form S-8 under the Securities Act of 1933, as amended (the “Act”), filed with the Securities and Exchange Commission (the “Commission”) on October 1, 2013 (the “Registration Statement”). This opinion is being furnished in connection with the requirements of Item 601(b)(5) of Regulation S-K under the Act, and no opinion is expressed herein as to any matter pertaining to the contents of the Registration Statement, other than as expressly stated herein with respect to the issue of the Shares.

As such counsel, we have examined such matters of fact and questions of law as we have considered appropriate for purposes of this letter. With your consent, we have relied upon certificates and other assurances of officers of the Company and others as to factual matters without having independently verified such factual matters. We are opining herein as to the General Corporation Law of the State of Delaware, and we express no opinion with respect to any other laws.

In our examination, we have assumed the genuineness of all signatures, the authenticity of all documents submitted to us as originals and the conformity to authentic original documents of all documents submitted to us as copies.

Subject to the foregoing and the other matters set forth herein, it is our opinion that, as of the date hereof, when the Shares have been duly registered on the books of the transfer agent and registrar therefor in the name or on behalf of the recipients, or certificates representing the Shares (in the form of the specimen certificate filed as an exhibit to the Company’s Registration Statement on Form S-1) have been manually signed by an authorized officer of the transfer agent and registrar therefor, and subject to the Company completing all actions and proceedings required on its part to be taken prior to the issuance of


October 1, 2013

Page 2

 

LOGO

 

the Shares, when the Shares have been issued by the Company in the circumstances contemplated by the Plans against requisite payment therefor, the issuance and sale of the Shares will have been duly authorized by all necessary corporate action of the Company, and the Shares will be validly issued, fully paid and nonassessable. In rendering the foregoing opinion, we have assumed that the Company will comply with all applicable notice requirements regarding uncertificated shares provided in the General Corporation Law of the State of Delaware.

This opinion is for your benefit in connection with the Registration Statement and may be relied upon by you and by persons entitled to rely upon it pursuant to the applicable provisions of the Act. We consent to your filing this opinion as an exhibit to the Registration Statement. In giving such consent, we do not thereby admit that we are in the category of persons whose consent is required under Section 7 of the Act or the rules and regulations of the Commission thereunder.

Very truly yours,

/s/ Latham & Watkins LLP